Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2015-03-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Broncho-Vascular Lung Sparing Reconstructions and Pneumonectomies in Patients With Non Small Cell Lung Cancer
NCT06835231
Plan for Systematic Identification of Lung Cancers of Occupational Origin: Implementation Study
NCT02696863
Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes
NCT07215026
Survival Outcomes of Lung Cancer
NCT03647098
Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer
NCT03505515
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The health-related quality of life will be assessed by EORTC-QLQ-C30, EQ-5D and EORTC-QLQ-LC13 in all different stages of lung cancer.
An utility measure will be considered. The preference values will be assessed via discrete choice experiment. Two scenarios will be designed and the lung cancer patients will be asked about the preferences.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to understand the overall concept of study and sign the written informed consent
Exclusion Criteria
* Visible cognitive impaired
* Non-primary lung tumor
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Nacional de Cardiologia de Laranjeiras
OTHER
Instituto Nacional de Cancer, Brazil
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carlos Gil Moreira Ferreira
MD PHD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos Gil Ferreira
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, France
Luciene Schluckebier
Role: STUDY_DIRECTOR
National Cancer Institute, France
Marisa Santos
Role: STUDY_CHAIR
INC
Bruna Carvalho
Role: STUDY_CHAIR
National Cancer Institute, France
Pedro Masson
Role: STUDY_CHAIR
National Cancer Institute, France
Andréa Monteiro
Role: STUDY_CHAIR
INC
Bruna Medeiros
Role: STUDY_CHAIR
INC
Kátia Senna
Role: STUDY_CHAIR
INC
Márcia Gisele
Role: STUDY_CHAIR
INC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
INCA - Instituto Nacional de Câncer
Rio de Janeiro, Rio de Janeiro, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INCA012015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.